By InvitationNot Applicable

UC Davis Cohort of Pre-Malignant and Malignant Gastro-Intestinal DisEases Study

United States1,000 participantsStarted 2021-07-13

Plain-language summary

To establish a prospective cohort of individuals diagnosed with gastric pre-malignant conditions (chronic gastritis, atrophic gastritis, autoimmune gastritis, intestinal metaplasia, intestinal dysplasia) to monitor and study disease progression. The Investigators will like to survey cohort participants for lifestyle behaviors and environmental exposures associated with gastric pre-malignancy and cancer. Analyzing patient biospecimens to identify and characterize host and microbiome biomarkers associated with initiation and progression of gastric pre-malignancies.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. UCDHS patients
✓. Of all races/ethnicities
✓. Diagnosed with premalignant conditions such as chronic gastritis, atrophic gastritis, autoimmune gastritis, gastric intestinal metaplasia, gastric intestinal dysplasia or gastic polyps
✓. During the last 5 years and current years to come (2015-2025)
✓. Some participants may be scheduled for endoscopy

What they're measuring

Pre-malignant progression

Timeframe: 2024

Trial details

NCT IDNCT05021029

SponsorUniversity of California, Davis

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-10-31

View on ClinicalTrials.gov More Intestinal Metaplasia trials